The Potential of Transcutaneous Electrical Nerve Stimulation to Improve Pain Experienced During Posterior Branch Blocks in Patients With Lumbar Posterior Joint Syndrome
TENS-INFIDOL
The Value of Transcutaneous Electrical Nerve Stimulation (TENS) for Improving Pain Experienced During Posterior Branch Blocks in Patients With Lumbar Posterior Joint Syndrome: a Single-center, Randomized, Double-blind, Parallel-group, Controlled, Superiority Trial
2 other identifiers
interventional
52
1 country
1
Brief Summary
Procedural pain is inadequately managed in two-thirds of patients undergoing invasive medical procedures. Several techniques exist for managing procedural pain, but they all present implementation challenges and are not without side effects. Therefore, a new, non-pharmacological, inexpensive, and easy-to-use approach would be of significant benefit. Transcutaneous electrical nerve stimulation (TENS) for pain relief could represent this alternative. Few studies have been conducted on the benefits of TENS in managing procedural pain, for example, in shoulder arthrodistension. This project proposes to study it in the context of posterior ramus infiltration in patients eligible for this indication, in the context of chronic low back pain associated with posterior joint syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2026
CompletedFirst Posted
Study publicly available on registry
June 4, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
Study Completion
Last participant's last visit for all outcomes
September 1, 2028
June 4, 2026
May 1, 2026
3 months
May 29, 2026
May 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of the intensity of pain experienced during the infiltration procedure between the intervention group and the placebo group
Pain assessment using the visual analog scale
3 months after the inclusion
Secondary Outcomes (3)
Evaluation of satisfaction with the infiltration procedure in both groups
3 months after the inclusion
Comparison of the effectiveness of posterior branch block on pain in both groups
3 months after the inclusion
Assessment of pain experienced by the patient in the 2 groups
3 months after the inclusion
Study Arms (2)
Interventional group with TENS in gate control mode
EXPERIMENTALInterventional group using TENS in gate control mode to allow the release of endorphins
Control group using TENS with placebo stimulation
ACTIVE COMPARATORControl group using TENS with placebo stimulation that does not release endorphins
Interventions
Stimulation with TENS at frequencies that allow the release of endorphins before infiltration
Stimulation with TENS at levels that do not allow the release of endorphins prior to infiltration
Pain questionnaires will need to be completed at the inclusion, one month and 3 months
Eligibility Criteria
You may qualify if:
- Chronic low back pain (lasting more than 3 months)
- Patient followed in a Chronic Pain Unit (CETD, Toulouse University Hospital)
- Clinical and radiological diagnosis (CT scan or MRI) of posterior joint syndrome
- Patient with an indication for infiltration therapy, feasible under standard conditions
You may not qualify if:
- Spinal surgery
- Contraindications for TENS:
- Wearing an electronic medical device (pacemakers, defibrillators, etc.)
- Pregnancy
- Area of cutaneous anesthesia
- Patient with an active malignant tumor
- Patient with deep vein thrombosis
- Patient with damaged or fragile skin
- Insulin-dependent or uncontrolled diabetes
- Uncontrolled hypertension
- Allergy to the local anesthetics used
- Severe psychiatric disorder
- Lumbar injection within the previous 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Neurologie, Hôpital Pierre Paul Riquet, Place du Docteur Baylac
Toulouse, 31300, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 29, 2026
First Posted
June 4, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
September 1, 2028
Last Updated
June 4, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share